-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Upgrades Replimune Group to Outperform, Raises Price Target to $19

Benzinga·08/07/2026 13:48:53
Listen to the news
Wedbush analyst Robert Driscoll upgrades Replimune Group (NASDAQ:REPL) from Neutral to Outperform and raises the price target from $12 to $19.